TY - JOUR
T1 - Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome from Myocardial Infarction
AU - Laumer, Fabian
AU - Di Vece, Davide
AU - Cammann, Victoria L.
AU - Würdinger, Michael
AU - Petkova, Vanya
AU - Schönberger, Maximilian
AU - Schönberger, Alexander
AU - Mercier, Julien C.
AU - Niederseer, David
AU - Seifert, Burkhardt
AU - Schwyzer, Moritz
AU - Burkholz, Rebekka
AU - Corinzia, Luca
AU - Becker, Anton S.
AU - Scherff, Frank
AU - Brouwers, Sofie
AU - Pazhenkottil, Aju P.
AU - Dougoud, Svetlana
AU - Messerli, Michael
AU - Tanner, Felix C.
AU - Fischer, Thomas
AU - Delgado, Victoria
AU - Schulze, P. Christian
AU - Hauck, Christian
AU - Maier, Lars S.
AU - Nguyen, Ha
AU - Surikow, Sven Y.
AU - Horowitz, John
AU - Liu, Kan
AU - Citro, Rodolfo
AU - Bax, Jeroen
AU - Ruschitzka, Frank
AU - Ghadri, Jelena Rima
AU - Buhmann, Joachim M.
AU - Templin, Christian
N1 - Funding Information:
Funding/Support: Dr Templin has been supported by the H.H. Sheikh Khalifa bin Hamad Al-Thani Research Program. The InterTAK Registry is supported by the Biss Davies Charitable Trust. Dr Laumer has been supported by PHRT - SHFN / SWISSHEART Failure Network (Dr Buhmann, PI).
Funding Information:
reported grants from PHRT - SHFN/SWISSHEART Failure Network with project number 2018-122 during the conduct of the study. Dr Delgado reported grants from Abbott Vascular paid to the department of Cardiology of LUMC, personal fees from Abbott Vascular, grants from Bayer paid to the department of Cardiology of LUMC, grants from Biotronik paid to the department of Cardiology of LUMC, grants from Bioventrix paid to the department of Cardiology of LUMC, grants from Boston Scientific paid to the department of Cardiology of LUMC, grants from Edwards Lifesciences paid to the department of Cardiology of LUMC, personal fees from Edwards Lifesciences, grants from GE Healthcare paid to the department of Cardiology of LUMC, personal fees from GE Healthcare, grants from Ionnis paid to the department of Cardiology of LUMC, grants from Medtronic paid to the department of Cardiology of LUMC, personal fees from Medtronic, personal fees from MSD, and personal fees from Novartis outside the submitted work. Dr Bax reported personal fees from Abbott speaker bureau, personal fees from Edwards Lifesciences speaker bureau, grants from Abbott, grants from Edwards Lifesciences, grants from Medtronic, grants from Boston Scientific, grants from Biotronik, and grants from GE Healthcare outside the submitted work. Dr Ruschitzka reported not receiving personal payments by pharmaceutical companies or device manufacturers in the last 3 years (remuneration for the time spent in activities, such as participation as steering committee member of clinical trials and member of the Pfizer Research Award selection committee in Switzerland, were made directly to the University of Zurich). The Department of Cardiology (University Hospital of Zurich/University of Zurich) reports research-, educational-and/or travel grants from Abbott, Amgen, AstraZeneca, Bayer, Berlin Heart, B. Braun, Biosense Webster, Biosensors Europe AG, Biotronik, BMS, Boehringer Ingelheim, Boston Scientific, Bracco, Cardinal Health Switzerland, Corteria, Daiichi, Diatools AG, Edwards Lifesciences, Guidant Europe NV (BS), Hamilton Health Sciences, Kaneka Corporation, Kantar, Labormedizinisches Zentrum, Medtronic, MSD, Mundipharma Medical Company, Novartis, Novo Nordisk, Orion, Pfizer, Quintiles Switzerland Sarl, Sahajanand IN, Sanofi, Sarstedt AG, Servier, SIS Medical, SSS International Clinical Research, Terumo Deutschland, Trama Solutions, V-Wave, Vascular Medical, Vifor, Wissens Plus, and ZOLL. The research and educational grants do not impact on Dr Ruschitzka’s personal remuneration. Dr Templin reported personal fees from Biotronik Consulting fees, personal fees from Microport Consulting, personal fees from Schnell Medical Consulting, personal fees from Novartis Lecture, and other from Amgen Advisory board outside the submitted work. No other disclosures were reported.
Publisher Copyright:
© 2022 American Medical Association. All rights reserved.
PY - 2022/5
Y1 - 2022/5
N2 - Importance: Machine learning algorithms enable the automatic classification of cardiovascular diseases based on raw cardiac ultrasound imaging data. However, the utility of machine learning in distinguishing between takotsubo syndrome (TTS) and acute myocardial infarction (AMI) has not been studied. Objectives: To assess the utility of machine learning systems for automatic discrimination of TTS and AMI. Design, Settings, and Participants: This cohort study included clinical data and transthoracic echocardiogram results of patients with AMI from the Zurich Acute Coronary Syndrome Registry and patients with TTS obtained from 7 cardiovascular centers in the International Takotsubo Registry. Data from the validation cohort were obtained from April 2011 to February 2017. Data from the training cohort were obtained from March 2017 to May 2019. Data were analyzed from September 2019 to June 2021. Exposure: Transthoracic echocardiograms of 224 patients with TTS and 224 patients with AMI were analyzed. Main Outcomes and Measures: Area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity of the machine learning system evaluated on an independent data set and 4 practicing cardiologists for comparison. Echocardiography videos of 228 patients were used in the development and training of a deep learning model. The performance of the automated echocardiogram video analysis method was evaluated on an independent data set consisting of 220 patients. Data were matched according to age, sex, and ST-segment elevation/non-ST-segment elevation (1 patient with AMI for each patient with TTS). Predictions were compared with echocardiographic-based interpretations from 4 practicing cardiologists in terms of sensitivity, specificity, and AUC calculated from confidence scores concerning their binary diagnosis. Results: In this cohort study, apical 2-chamber and 4-chamber echocardiographic views of 110 patients with TTS (mean [SD] age, 68.4 [12.1] years; 103 [90.4%] were female) and 110 patients with AMI (mean [SD] age, 69.1 [12.2] years; 103 [90.4%] were female) from an independent data set were evaluated. This approach achieved a mean (SD) AUC of 0.79 (0.01) with an overall accuracy of 74.8 (0.7%). In comparison, cardiologists achieved a mean (SD) AUC of 0.71 (0.03) and accuracy of 64.4 (3.5%) on the same data set. In a subanalysis based on 61 patients with apical TTS and 56 patients with AMI due to occlusion of the left anterior descending coronary artery, the model achieved a mean (SD) AUC score of 0.84 (0.01) and an accuracy of 78.6 (1.6%), outperforming the 4 practicing cardiologists (mean [SD] AUC, 0.72 [0.02]) and accuracy of 66.9 (2.8%). Conclusions and Relevance: In this cohort study, a real-time system for fully automated interpretation of echocardiogram videos was established and trained to differentiate TTS from AMI. While this system was more accurate than cardiologists in echocardiography-based disease classification, further studies are warranted for clinical application.
AB - Importance: Machine learning algorithms enable the automatic classification of cardiovascular diseases based on raw cardiac ultrasound imaging data. However, the utility of machine learning in distinguishing between takotsubo syndrome (TTS) and acute myocardial infarction (AMI) has not been studied. Objectives: To assess the utility of machine learning systems for automatic discrimination of TTS and AMI. Design, Settings, and Participants: This cohort study included clinical data and transthoracic echocardiogram results of patients with AMI from the Zurich Acute Coronary Syndrome Registry and patients with TTS obtained from 7 cardiovascular centers in the International Takotsubo Registry. Data from the validation cohort were obtained from April 2011 to February 2017. Data from the training cohort were obtained from March 2017 to May 2019. Data were analyzed from September 2019 to June 2021. Exposure: Transthoracic echocardiograms of 224 patients with TTS and 224 patients with AMI were analyzed. Main Outcomes and Measures: Area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and specificity of the machine learning system evaluated on an independent data set and 4 practicing cardiologists for comparison. Echocardiography videos of 228 patients were used in the development and training of a deep learning model. The performance of the automated echocardiogram video analysis method was evaluated on an independent data set consisting of 220 patients. Data were matched according to age, sex, and ST-segment elevation/non-ST-segment elevation (1 patient with AMI for each patient with TTS). Predictions were compared with echocardiographic-based interpretations from 4 practicing cardiologists in terms of sensitivity, specificity, and AUC calculated from confidence scores concerning their binary diagnosis. Results: In this cohort study, apical 2-chamber and 4-chamber echocardiographic views of 110 patients with TTS (mean [SD] age, 68.4 [12.1] years; 103 [90.4%] were female) and 110 patients with AMI (mean [SD] age, 69.1 [12.2] years; 103 [90.4%] were female) from an independent data set were evaluated. This approach achieved a mean (SD) AUC of 0.79 (0.01) with an overall accuracy of 74.8 (0.7%). In comparison, cardiologists achieved a mean (SD) AUC of 0.71 (0.03) and accuracy of 64.4 (3.5%) on the same data set. In a subanalysis based on 61 patients with apical TTS and 56 patients with AMI due to occlusion of the left anterior descending coronary artery, the model achieved a mean (SD) AUC score of 0.84 (0.01) and an accuracy of 78.6 (1.6%), outperforming the 4 practicing cardiologists (mean [SD] AUC, 0.72 [0.02]) and accuracy of 66.9 (2.8%). Conclusions and Relevance: In this cohort study, a real-time system for fully automated interpretation of echocardiogram videos was established and trained to differentiate TTS from AMI. While this system was more accurate than cardiologists in echocardiography-based disease classification, further studies are warranted for clinical application.
UR - http://www.scopus.com/inward/record.url?scp=85128559226&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2022.0183
DO - 10.1001/jamacardio.2022.0183
M3 - Article
C2 - 35353118
AN - SCOPUS:85128559226
SN - 2380-6583
VL - 7
SP - 494
EP - 503
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 5
ER -